These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26740894)

  • 1. Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.
    Kınay T; Küçük C; Kayıkçıoğlu F; Karakaya J
    Balkan Med J; 2015 Oct; 32(4):359-63. PubMed ID: 26740894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome.
    Gul A; Cebeci A; Aslan H; Polat I; Ozdemir A; Ceylan Y
    Gynecol Obstet Invest; 2005; 59(2):113-8. PubMed ID: 15591806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?
    Guzel AI; Kuyumcuoglu U; Celik Y
    Arch Gynecol Obstet; 2011 Jun; 283(6):1227-32. PubMed ID: 20526778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?
    Abramovici D; Friedman SA; Mercer BM; Audibert F; Kao L; Sibai BM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):221-5. PubMed ID: 9914607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome.
    Yıldırım G; Güngördük K; Aslan H; Gül A; Bayraktar M; Ceylan Y
    J Turk Ger Gynecol Assoc; 2011; 12(2):90-6. PubMed ID: 24591969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
    Bombrys AE; Barton JR; Nowacki EA; Habli M; Pinder L; How H; Sibai BM
    Am J Obstet Gynecol; 2008 Sep; 199(3):247.e1-6. PubMed ID: 18771971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal salvage by week's gestation in pregnancies complicated by HELLP syndrome.
    Magann EF; Perry KG; Chauhan SP; Graves GR; Blake PG; Martin JN
    J Soc Gynecol Investig; 1994; 1(3):206-9. PubMed ID: 9419772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Aug; 183(2):444-8. PubMed ID: 10942484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectant management of severe preeclampsia presenting before 25 weeks of gestation.
    Sezik M; Ozkaya O; Sezik HT; Yapar EG
    Med Sci Monit; 2007 Nov; 13(11):CR523-527. PubMed ID: 17968301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations.
    Sullivan CA; Magann EF; Perry KG; Roberts WE; Blake PG; Martin JN
    Am J Obstet Gynecol; 1994 Oct; 171(4):940-3. PubMed ID: 7943105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
    Lisonkova S; Bone JN; Muraca GM; Razaz N; Wang LQ; Sabr Y; Boutin A; Mayer C; Joseph KS
    Am J Obstet Gynecol; 2021 Nov; 225(5):538.e1-538.e19. PubMed ID: 33974902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of severe preeclampsia and HELLP syndrome].
    Rath W; Bartz C
    Zentralbl Gynakol; 2004 Oct; 126(5):293-8. PubMed ID: 15478045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study.
    Lisonkova S; Razaz N; Sabr Y; Muraca GM; Boutin A; Mayer C; Joseph KS; Kramer MS
    BJOG; 2020 Sep; 127(10):1189-1198. PubMed ID: 32189413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difference between preeclampsia, HELLP syndrome and eclampsia, maternal evaluation].
    Vigil-de Gracia PE; Tenorio-Marañón FR; Cejudo-Carranza E; Helguera-Martínez A; García-Cáceres E
    Ginecol Obstet Mex; 1996 Aug; 64():377-82. PubMed ID: 8925990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center.
    Gaugler-Senden IP; Huijssoon AG; Visser W; Steegers EA; de Groot CJ
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):216-21. PubMed ID: 16359774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
    Demir SC; Evruke C; Ozgunen FT; Urunsak IF; Candan E; Kadayifci O
    Saudi Med J; 2006 Jul; 27(7):1015-8. PubMed ID: 16830022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal outcomes in severe preeclamptic women between 24-33(+6) weeks' gestation.
    Jantasing S; Tanawattanacharoen S
    J Med Assoc Thai; 2008 Jan; 91(1):25-30. PubMed ID: 18386540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets).
    Magann EF; Roberts WE; Perry KG; Chauhan SP; Blake PG; Martin JN
    Am J Obstet Gynecol; 1994 Jun; 170(6):1828-32; discussion 1832-4. PubMed ID: 8203445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.